LOBE Share Price Performance
CA$0.05
0.03 (150.00%)
Price CA$0.05
Share PriceCA$0.05
LOBE Community Narratives
There are no narratives available yet.
Recent LOBE News & Updates
No updates
Lobe Sciences Ltd. Key Details
Last Reported Earnings
May 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.026
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 73.0%
Lobe Sciences Ltd. Competitors
About LOBE
- Founded
- 2018
- Employees
- n/a
- CEO
- WebsiteView website
Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. was founded in 2018 and is headquartered in Vancouver, Canada.
Canadian Market Performance
- 7 Days: 0.4%
- 3 Months: 7.1%
- 1 Year: 21.0%
- Year to Date: 9.9%
The Materials sector gained 6.6% while the market remained flat over the last week. Meanwhile, the market is actually up 21% over the past year. Looking forward, earnings are forecast to grow by 11% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading